You are here

Study Evaluating Totelle® in Menopausal Symptoms and Sexual Function

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Jundiai, Sao Paulo, 13209-000 Brazil
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hot Flashes, Sleep Disorders
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
45-60 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Intact uterus

- Generally health postmenopausal women 45 to 60 years of age, inclusive

- Sexually active

- No hormone replacement therapy within the 90 days immediately prior to the screening
evaluation.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Known or suspect estrogen-dependent neoplasia

- Known hypersensitivity to estrogens, progestins, or other ingredients of Totelle

- Use of any estrogen, progestin, androgen containing medications or tibolone within 12
weeks before screening.

NCT00195520
Pfizer
Completed
Study Evaluating Totelle® in Menopausal Symptoms and Sexual Function

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now